Pharmaceutical Industry Blog

Tafasitamab is an investigational immunotherapy designed to treat certain types of cancer by targeting the CD19 receptor on B cells. This...

Inebilizumab is an investigational immunotherapy designed to treat certain autoimmune conditions by targeting the CD19 receptor on B...

Denintuzumab is an investigational immunotherapy designed to treat certain types of cancer by targeting the CD19 receptor on B cells....

Coltuximab is an investigational immunotherapy designed to treat certain types of cancer by targeting the CD19 receptor on B cells. This...

Utomilumab is an investigational immunotherapy designed to treat certain types of cancer by targeting the 4-1BB (CD137) receptor on T...

Bifikafusp alfa is an investigational immunotherapy designed to treat certain types of cancer by targeting the extradomain B of...